Edwards lifesciences corporation investigation ongoing: contact levi & korsinsky about potential securities fraud allegations - ew

New york, ny / accesswire / september 30, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of edwards lifesciences corporation ("edwards lifesciences") (nyse:ew) concerning possible violations of federal securities laws. on october 28, 2022, edwards announced 3q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4q.
EW Ratings Summary
EW Quant Ranking